Absence of CD34 on Murine Skeletal Muscle Satellite Cells Marks a Reversible State of Activation during Acute Injury by Ieronimakis, Nicholas et al.
Absence of CD34 on Murine Skeletal Muscle Satellite
Cells Marks a Reversible State of Activation during Acute
Injury
Nicholas Ieronimakis
1, Gayathri Balasundaram
1, Sabrina Rainey
1, Kiran Srirangam
1, Zipora
Yablonka-Reuveni
2, Morayma Reyes
1*
1Department of Pathology, School of Medicine, University of Washington, Seattle, Washington, United States of America, 2Department of Biological Structure, School of
Medicine, University of Washington, Seattle, Washington, United States of America
Abstract
Background: Skeletal muscle satellite cells are myogenic progenitors that reside on myofiber surface beneath the basal
lamina. In recent years satellite cells have been identified and isolated based on their expression of CD34, a sialomucin
surface receptor traditionally used as a marker of hematopoietic stem cells. Interestingly, a minority of satellite cells lacking
CD34 has been described.
Methodology/Principal Findings: In order to elucidate the relationship between CD34+ and CD34- satellite cells we utilized
fluorescence-activated cell sorting (FACS) to isolate each population for molecular analysis, culture and transplantation
studies. Here we show that unless used in combination with a7 integrin, CD34 alone is inadequate for purifying satellite
cells. Furthermore, the absence of CD34 marks a reversible state of activation dependent on muscle injury.
Conclusions/Significance: Following acute injury CD34- cells become the major myogenic population whereas the
percentage of CD34+ cells remains constant. In turn activated CD34- cells can reverse their activation to maintain the pool
of CD34+ reserve cells. Such activation switching and maintenance of reserve pool suggests the satellite cell compartment is
tightly regulated during muscle regeneration.
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Introduction
Since their discovery, satellite cells have been characterized as
the resident stem cells of the skeletal muscle, responsible for
postnatal myofiber growth and regeneration [1,2]. Classically,
satellite cells have been defined by their position underneath the
basal lamina of muscle fibers. More recently, satellite cells have
been distinguished by nuclear Pax7 immunostaining and/or
Myf5
nlacZ/+ reporter expression, and the presence of various
surface receptors including a7 integrin (herein referred
as a7), b1 integrin, CD34, NCAM, c-met, and CXCR4
[3,4,5,6,7,8,9,10,11,12]. Although satellite cells are unanimously
recognized by anatomical location, there is no single surface
marker specific or exclusive to the entire population. This issue is
compounded by the heterogeneity of satellite cells between
muscles, as reported with Pax3 expression, and within muscles,
based on non-uniform expression levels of Myf5-driven reporters
[13,14,15]. Such heterogeneity between and within various
muscles exemplifies the complexity of the satellite cell pool that
has yet an established canonical differentiation lineage.
Beauchamp et al. (2000) reported that the majority of satellite
cells could be identified by Myf5-knock-in reporter activity and
CD34 expression. In this study approximately 20% of satellite cells
monitored in freshly isolated myofibers from extensor digitorum
longus (EDL) muscle, could not be detected by CD34 immuno-
staining. Although the CD34- satellite cell population was not
characterized, it was suggested these cells may represent a more
primitive population of muscle stem cells [5]. In separate studies
using Pax3 and Pax7 reporter mice, it was observed that the
majority of myogenic cells of skeletal muscle reside within the
CD34+ fraction [16,17]. It has been further described that
myogenic cells can be isolated by fluorescence-activated cell
sorting (FACS) as CD452/Sca12/CD34+, and more recently as
CD452/CD312/Sca12/CD11b2/a7+/CD34+ [18,19].
Although CD34 has been used to identify and isolate satellite
cells, many cell types, including muscle endothelial cells, express
CD34 [20]. Thus, in order to study satellite cell heterogeneity, we
initially set out to develop a method to isolate pure populations of
satellite cells using the CD34 antigen while excluding other cells
that may also express CD34. Utilizing FACS based on previously
PLoS ONE | www.plosone.org 1 June 2010 | Volume 5 | Issue 6 | e10920published reports from this and other laboratories, we initially
isolated satellite cells by removing CD45+ hematopoietic cells,
CD31+ endothelial cells, other non-satellite Sca1+ cells, and then
selecting the remaining CD34+ fraction [18,20,21]. Although the
bulk of CD452/CD312/Sca12/CD34+ sorted cells were
myogenic, we repeatedly observed non-myogenic cells in culture.
Next, in accordance with the literature, we incorporated a7 for
satellite cell FACS isolation [10,14,19,22]. Indeed, this approach
eliminated non-myogenic cells in culture. Subsequently, we
observed by FACS-analysis that the CD452/CD312/Sca12/
a7+ population was comprised of a CD34+ majority and CD342
minority. In the murine hematopoietic system it has been observed
that single CD342/low stem cells can reconstitute the entire
hematopoietic system and give rise to both CD34+/2 cells [23].
Therefore, in analogy with the hematopoietic system, we initially
hypothesized that within the satellite cell compartment the
minority of CD342 cells may represent more primitive cells
upstream of the more abundant CD34+ population. However, our
results described herein indicate the absence of CD34 on skeletal
muscle satellite cells in vivo marks a state of activation dependent on
muscle injury and not necessarily a hierarchy as initially predicted.
Results
Despite CD45/CD31/Sca1 Negative Selection, CD34 is
Insufficient for Purifying Satellite Cell by Flow Cytometry
Using our previously developed method to isolate endothelial
cells from a collection of skeletal muscles (pooled hind limb,
pectoralsand triceps muscles), weinitiallyFACS-sortedsatellite cells
as CD452/CD312/Sca12/CD34+ [20]. Reverse-transcription
PCR (RT-PCR) of these freshly sorted cells revealed expression of
Pax7 and myogenic factors Myf5 and MyoD (data not shown). In
culture, the majority of CD452/CD312/Sca12/CD34+ sorted
cells produced colonies comprised of small round cells that
ultimately formed twitching myotubes. However, cultured
CD452/CD312/Sca12/CD34+ cells also gave rise to larger
non-myogenic cells that never formed myotubes (data not shown).
To improve satellite cell purification we incorporated a7 and
investigated the myogenic potential within the CD452/CD312/
Sca12 population based on the presence or absence of a7 and
CD34 antigens. By FACS-mediated single cell deposition only
CD34+/a7+ (CD452/CD312/Sca12) sorted cells, which were
small and round, gave rise to myogenic colonies (n=3). In
contrast, CD34+/a72 (CD452/CD312/Sca12) cells appeared
larger and more spread-out and did not form myotubes
(n=3)(Figure 1A). Quantitative reverse-transcription PCR (q-
RT-PCR) of freshly sorted cells (n=2) revealed that between these
two populations, only CD34+/a7+ cells express the definitive
satellite cells genes Pax7 and Myf5 (Figure 1B). Cryosections from
uninjured tibialis anterior (TA) muscle, immunostainied for Pax7,
a7 and CD34, revealed the presence of both populations.
However, only CD34+/a7+ cells were Pax7+ and within the
satellite cell position. CD34+/a72 cells were Pax72 and located
in the interstitium (Figure 1C). Altogether, our results indicate
CD34+/a7+ cells are present in the satellite cell compartment
while CD34+/a72 cells are not myogenic in culture nor satellite
cells by anatomical definition.
By FACS-analysis we determined that a72 cells constitute
11.8% (61.2% SEM) of the CD452/CD312/Sca12/CD34+
population (n=5); note with the exception of transplant studies
and reporter mice, all experiments characterizing CD34+/2 cells
were completed with 2 month old C57BL/6 male mice. We
believe sorted CD34+/a72 cells, which correspond with CD34+/
a72/Pax72 cells observed by immunostaining, were the source of
non-myogenic CD452/CD312/Sca12/CD34+ cells. Collec-
tively, our results are consistent with previous reports that CD34
is present on the majority of skeletal muscle satellite cells.
However, because CD34 cell surface expression is not exclusive
to satellite cells, it is insufficient to FACS purify satellite cells unless
used in conjunction with a second positive antigen such as a7.
CD342/a7+ (CD452/CD312/Sca12) Cells Represent a
Minority of Limb Muscle Pax7+ Satellite Cells
When purifying a7+ (CD452/CD312/Sca12) cells, we
observed CD34+ majority and CD342 minority populations,
both of which produced myogenic colonies in culture. These
CD34+/2 populations sorted as CD452/CD312/Sca12/a7+
shall be abbreviated CD34+ and CD342 for the remainder of this
manuscript. FACS-analysis indicates CD342 cells make up
,17.6% (62.2% SEM) of the a7+ (CD452/CD312/Sca12)
population in pooled muscle preparations from individual mice
(n=5). Further antibody staining revealed the presence of
CD342/Pax7+ cells in the satellite cell position underneath the
basal lamina; confirming CD342 cells are an integral part of the
satellite cell niche in vivo and not a mere product of cell isolation
procedures (Figure 2). Satellite cells constitute only 2–5% of the
nuclei in adult muscles and their abundance varies between muscle
type and age [24,25]. Therefore, direct quantification from cross
sections would have required that many samples and cross sections
be analyzed for accurate numbers of CD34+ and CD342, Pax7+
satellite cells. Thus in order to quantify the abundance of these two
satellite cell populations, we performed flow cytometry analysis of
pooled muscles as well as individual muscles.
Analysis of myogenic colonies generated by FACS-mediated
single cell deposition of CD34+/2 satellite cells (1 cell per well, 96
wells per cell type from each mouse, n=3) revealed that both
populations contributed myogenic clones with similar growth
pattern based on the number of nuclei counted from each colony
(Figure 3A, cell doubling). However, clonability was higher in the
CD34+ versus the CD342 population (Figure 3A, #colonies/per
96 wells). The difference observed between the number of wells
with colonies, suggests the CD34+ population exhibits greater
cloning efficiency. Alternatively, our culture conditions may not be
optimal for seeding CD342 sorted cells.
As noted above, all Pax7+ cells were a7+ (Figure 1C). However,
not all a7+ cells were Pax7+. The microvascular bed, especially
vascular smooth muscle cells stained positive for a7 (data not
shown)[26,27]. However, in the event that any endothelial cells
may be a7+, such putative endothelial cells are CD31+ and are
excluded from the CD452/CD312/Sca12/a7+ population.
Indeed, RT-PCR of freshly sorted cells (n=3) for von Willebrand
Factor and Tie1, genes expressed by skeletal muscle endothelium,
confirms the absence of endothelial cells within both sorted cell
populations (Figure 3B) [20]. Additionally vascular smooth muscle
cells within skeletal muscles immunostained negative for CD34
and thus were presumed to be excluded from the sorted CD34+
population (not shown)[28]. Although such vascular smooth
muscle cells could potentially be present in the CD342 satellite
cell population, our sort approach should eliminate the presence of
such cells from the final population. As previously published,
satellite cells have also been defined as small non-granulated cells
based on FACS-analysis [13]. Likewise, in our FACS isolation of
satellite cells, we gate on smaller events by forward scatter (FSC)-
Area vs. FSC-Height to remove larger a7+ cells that may originate
from vascular smooth muscle (Figure S1).
To assess satellite cell purity within each population, we
cytocentrifuged freshly sorted CD34+/2 cells (n=3 mice) and
immunostained with anti-Pax7. From both sorted populations we
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presence of nuclear Pax7 staining (Figure 4A, left panels). On
average, 89% (61.7% SEM) of CD34+ and 70% (62.6% SEM) of
CD342 cells stained positive for Pax7. Although the majority of
cytocentrifuged cells from both populations stained positive, the
difference in the frequency of Pax7+ cell was significant (Student’s
t-test, P=0.04) indicating there is some contribution of Pax7- cells
within the CD342 population.
We also cytocentrifuged CD34+ and CD342 cells sorted from
adult 3F-nlacZ-2F reporter mice to assess the possible presence of
differentiated progeny of satellite cells in the CD34+/2 popula-
tions. In this transgenic mouse, muscle fibers and cultured
differentiated myoblasts and myotubes express nuclear localized
LacZ [5,15,29]. Nuclei positive for b-galactosidase (b-gal) were
identified by X-gal staining (data not shown). We observed that
CD342 cells were completely negative, while approximately
0.01% of CD34+ cells stained positive for b-gal activity with X-gal.
With the exception of the few CD34+/b2gal+ cells observed, lack
of 3F-nlacZ-2F reporter activity indicated the vast majority of cells
in the CD34+/2 sorted populations were not differentiated
myoblasts (the phase at which this transgene is activated) [5,29]. In
contrast, we did identify b-gal+ cells from cytocentrifuged
Figure 1. CD34+/a7 integrin- cells are not myogenic nor anatomically defined satellite cells. (A) Colonies derived from FACS-mediated
single cell deposition of CD34+/a72 and CD34+/a7+ (CD452/CD312/Sca12) cells (n=3). Only a7+ sorted cells gave rise to colonies of small round
myogenic cells. (B) q-RT-PCR of freshly sorted cells (n=2) indicates only a7+ cells express Pax7 and Myf5. *** denotes P#0.00005 calculated by
Student’s t-test. Error bars represent 6SEM. (C) Immunostained TA cryosections reveal Pax7+ satellite cells are CD34+/a7+ (arrow) while CD34+/a72
cells sighted within interstitium were Pax7- (arrow head). Negative controls for all stainings are depicted in Figure S4. Scale bars=50 mm.
doi:10.1371/journal.pone.0010920.g001
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(not shown).
To assess the in vitro myogenic potential of these two
populations, we cultured CD34+/2 sorted cells from 3F-nlacZ-
2F (n=2, pooled) and Myf5
nlacZ/+ mice (n=3). Cultured
CD34+/2 cells sorted from Myf5
nlacZ/+ and 3F-nlacZ-2F mice
produced progeny that looked identical in culture (Figure 4A,
middle and right panels). From Myf5
nlacZ/+ mice, both populations
formed myogenic colonies with numerous b-gal+ myonuclei and
myoblasts. Myonuclei from Myf5
nlacZ/+ mice stained positive with
X-gal due to the presence of residual b-gal expressed also in
differentiating cells [15]. In contrast, 3F-nlacZ-2F reporter activity
was predominantly localized in myonuclei.
To further compare the CD34+/2 populations, we surveyed
the expression of genes known to be transcribed by satellite cells
(Figure 4B). Due to possible gene regulation changes in culture
that may not necessarily represent in vivo expression, we chose to
analyze only freshly sorted cells by q-RT-PCR. Initially we
checked CD34 and a7 expression to validate our FACS-analysis
(Figure 4B). In accordance with antigen levels, CD342 cells
express very low levels of CD34 mRNA, whereas CD34+ cells
transcribe much higher levels (25 times greater than CD342 cells).
The expression of a7 was similar in both CD34+/2 populations
and not statistically significant (Student’s t-test, P.0.05). Next, we
compared the two populations for the expression of a panel of
genes that are associated with different phases of myogenesis
(Figure 4B). Pax3, Pax7, and Myf5 are expressed by quiescent and
proliferating satellite cells [4,12,30,31]. MyoD expression is
initiated upon satellite cell activation and sustained in proliferating
and differentiating progeny, while myogenin expression is associated
specifically with myogenic differentiation [11,32]. Interestingly,
expression levels of Pax3/7 genes and muscle regulatory factors
Figure 2. CD34+ and CD34- cells are Pax7+ satellite cells of the skeletal muscle. Cryosections of tibialis anterior (TA) muscle immunostained
for Pax7, laminin, and CD34 show the existence of CD342 satellite cells. Both CD342/Pax7+ (arrow head) and CD34+/Pax7+ (arrow) cells were
sighted in the satellite position under the basal lamina. Scale bar=50 mm.
doi:10.1371/journal.pone.0010920.g002
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CD34+ vs. CD342 cells (Student’s t-test, P#0.05). The detection
of myogenin suggests the presence of some differentiating myogenic
cells, which may account for the presence of a minute number of
cytocentrifuged CD34+ cells that stained positive with X-gal for
the differentiation-linked 3F-nlacZ-2F reporter as detailed above.
Our detection of myogenin and MyoD transcripts, in addition to
Myf5, in preparation of freshly isolated satellite cells is in
agreement with previous studies describing gene expression in
freshly isolated satellite cells [33,34]. Expression of satellite cell
associated genes CXCR4, c-met and NCAM was also significantly
higher in CD34+ cells (Student’s t-test, P#0.05). Collectively, this
expression comparison suggests that CD34+ cells transcribe higher
levels of satellite cell characteristic genes than CD342 cells.
Alternatively, the CD342 population may contain a residual
population of non-myogenic cells that contributes to the apparent
reduced expression of these genes.
The CD34+ and CD342 Populations are Consistently
Maintained Across Different Muscles
In the aforementioned experiments, we isolated CD34+/2 cells
from pooled hindlimb, pectoralis and triceps muscles. In contrast,
the study by Beauchamp et al. (2000) quantified the percentage of
CD34+ satellite cells only on EDL single fiber isolations. Thus, to
address the possibility that CD342 satellite cells reside only in
specific skeletal muscles, we FACS-analyzed individual muscles
(n=5) using same selection strategy used for pooled muscle
isolations (Figure 5A). Because the number of hematopoietic cells
can vary between mice depending on circulatory responses, such
as mild inflammation, we restricted our analysis to the CD452
fraction. For each muscle, Figure 5B represents the average
percentage of CD34+/2 cells compared to the total number of
non-hematopoietic mononuclear cells. Figure 5C represents the
average percentage within the a7+ (CD452/CD312/Sca12)
population in order to determine if CD34+ cells consistently
represent the majority.
Results from individual muscle analyses indicate that the
average percentage of CD34+ cells compared to the CD452
fraction is consistent between hindlimb muscles, whereas pectoralis
and triceps contain nearly twice the amount of CD34+ cells. Such
variation in the number of CD34+ cells may be attributed to
individual muscle demands for myogenic cells and/or myofiber
types. Consequently, the percentage of CD34+ cells was
statistically different (single factor ANOVA, p#0.05) between
muscle groups, whereas the percentage of CD342 cells was not
(P=0.075), indicating this population is consistently present in all
muscle groups analyzed. Despite this variation, CD34+ cells were
consistently the majority within the a7+ (CD452/CD312/
Sca12) population. The ratio of CD34+ over CD342 cells was
not statistically significant (single factor ANOVA, p.0.05),
suggesting the distribution of these two populations is maintained
between muscle groups.
Following Acute Injury, CD342 Cells Represent the
Majority of Activated a7+ (CD452/CD312/Sca12)
Myogenic Cells
To elucidate the role of CD342 skeletal muscle cells of the
skeletal muscle we examined their response to acute injury using
the cardiotoxin (CTX) model. Such injury is characterized by a
massive myogenic response leading to almost full muscle
regeneration by week two following initial tissue destruction
[35,36]. We injected CTX in left TA’s and FACS-analyzed each
damaged muscle individually at 3, 7, and 14 days post injury (n=5
per time point)(Figure 6A&B). Just as the previous analysis of
individual muscles, we compared here the percentage of
CD34+/2 cells within the CD452 fraction (Figure 6A) and the
relative percentage within all a7+ (CD452/CD312/Sca12) cells
(Figure 6B). For this experiment we predicted that the more
differentiated population will increase early after injury and
continuously decrease from day 7 to14 as the muscle reaches full
regeneration. In addition, if there is a canonical relationship
between CD34+/2 cells, we have anticipated an inverse trend
where one population decreases while the other increases during
the course of regeneration.
Figure 3. CD34+/2 sorted cells represent clonal non-endothelial
myogenic populations. (A) FACS-mediated single cell deposition
indicates both populations had similar proliferation rates, although
CD34+ cells gave rise to more colonies. Y-axis denotes the average number
of colonies per 96 well plate or cell doublings. Although CD34+ single cells
gave rise to more colonies, both populations were equally myogenic in
culture (B) RT-PCR of freshly sorted cells for endothelial cell expressed genes
von Willenbrand Factor (vWF)a n dTie1 confirms no contamination from
CD34+/a7+ capillaries. Both A and B are from 2 month old, n=3 C57BL/6
mice. Student’s t-test, * P=0.05. Error bars represent 6SEM.
doi:10.1371/journal.pone.0010920.g003
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the number of a7+ (CD452/CD312/Sca12) cells which by
histology were not vascular smooth muscle cells as indicated by a-
smooth muscle actin (aSMA) staining (Figure S2). Surprisingly
after CTX injury, the CD34- cells became the majority and
declined to near uninjured levels by day 14. In contrast, the
average percentage of CD34+ cells remained between 3–5%
within the CD452 fraction (Figure 6A) despite becoming the
minority within a7+ (CD452/CD312/Sca12) population
(Figure 6B). The fluctuation of CD342 cells between time points
Figure 4. CD34+/2 sorted populations contain a similar number of satellite cells that vary in gene expression. (A) The majority of
freshly sorted cytocentrifuged CD34+/2 cells stained positive for Pax7 DAB; 89% (61.7% SEM) of CD34+ and 70% (62.6% SEM) of CD342 cells were
positive (n=3, 2 month old C57BL/6). Although this difference was statistically significant (Students t-test, P#0.05), the majority of CD34+ and
CD342 cells were Pax7+ indicating a high purity of satellite cells within both populations. Arrowheads indicate Pax7+ cells while line arrows point to
Pax7- cells. Cultured CD34+/2 cells from Myf5
nlacZ/+ and 3F-nlacZ-2F mice gave rise to b-galactosidase+ myogenic colonies as indicated by X-gal
staining. The presence of Myf5
nlacZ/+ and 3F-nlacZ-2F reporters in culture suggests both populations have similar myogenic potential. 606scale bar
for cytocentrifuged photos was unavailable. Scale bars for cultured cells=50 mm. (B) q-RT-PCR of freshly sorted cells confirms a7 expression in both
populations and low CD34 expression in CD342 cells (n=3, 2 month old C57BL/6). Although higher in CD34+ cells, both populations expressed
satellite cell markers Pax3/7, and myogenic regulatory factors Myf5, MyoD, and myogenin. Expression of satellite cell associated genes CXCR4, c-met,
and NCAM was also higher in CD34+ cells. Student’s t-test calculated * P#0.05 and ** P#0.005. Error bars represent 6SEM.
doi:10.1371/journal.pone.0010920.g004
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CD34+/2 populations. Following size selection, hematopoietic cells are removed by selecting only CD452 cells. Endothelial and other non-satellite
cells are then removed by gating on CD312/Sca12 cells. Finally within the a7+ (CD452/CD312/Sca12) population, CD34+/2 cells are selected. Red
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significant (single factor ANOVA, p#0.05). However, the
percentage of CD34+ cells within the CD452 fraction remained
relatively constant (p=0.076).
Since CD34+ cells became the minority within the a7+
(CD452/CD312/Sca12) population early in injury but the
overall percentage of these cells did not increase, we postulated this
population remained quiescent while CD342 cells were activated.
Thus, we compared Myf5, MyoD, and myogenin expression by q-
RT-PCR in freshly sorted cells from damaged limb muscles at 3
days post CTX injury (Figure 6C). Cells were sorted from pooled
CTX injected muscles (single TA, quadriceps and gastrocnemius)
from individual mice (n=3). Without injury both CD34+/2 cells
expressed relative high levels of Myf5 but low levels of MyoD and
myogenin mRNA, indicating both populations are committed to the
myogenic pathway, but remain quiescent in uninjured muscle
(Figure 4B). In contrast, following injury the average relative
expression of all three MRF’s increased in both populations
(Figure 6C). Myf5 and MyoD expression was similar between both
populations whereas myogenin was 3.9 times greater and statistically
significant (Student’s t-test, p#0.05) in CD342 cells. In accor-
dance with MRF expression during myogenesis, upregulation of
Myf5 and MyoD following injury indicates both CD34+/2 cells are
activated while higher myogenin expression suggests that more
differentiated cells reside within the CD342 population [11].
The significance of myogenin expression was confirmed by
immunostaining as the majority of myogenin+ cells observed
within damaged areas 3 days post CTX injury, were a7+/CD342
(Figure 7A). Taking into account myogenin histological and FACS
data we concluded CD342 cells were directly responding to
injury. In contrast, significant upregulation of MyoD but not
myogenin by CD34+ cells suggested this population was activated
but not differentiating. However, the role of CD34+ cells following
injury was unclear as their overall numbers did not increase while
the majority of a7+ cells observed within damaged areas were
CD342.
Although Both CD34+/2 Populations Proliferate in
Response to Injury, CD34+ Cells Retain More BrdU
Because the percentage of CD34+ cells did not increase with
CTX damage, it was possible that there was a general increase in
all cell types or that CD34+ cells did not proliferate in response to
injury. To explore this alternative, we compared BrdU incorpo-
ration in order to quantify proliferation between CD34+/2 cells
and asses if the absence of CD34 simply marks mitotically active
myogenic cells. In order to test this hypothesis we analyzed BrdU
incorporation without injury, 2.5–3 days post injury within the
peak of proliferation, and after regeneration 14 days post injury
(n=3 for each timepoint analyzed)(Figure 7B)[35]. Bone marrow
cells isolated from the same animals as a positive control had a
high degree of BrdU incorporation following 3 days pulse. In
contrast, BrdU was not detected in CD34+ or CD342 cells from
uninjured limb. However, upon injury, BrdU was incorporated
into the CD34+/2 populations. When isolated from mice pulsed
for 12 hours between day 2.5–3 post CTX injury, both CD34+/2
populations had incorporated equally high levels of BrdU.
Interestingly, in cells isolated from mice pulsed for the first 3
days following injury and then chased to day 14, BrdU
incorporation declined in CD342 cells but remained the same
for CD34+ cells. Consequently, the amount BrdU retention by
day 14 was roughly 10 fold greater for CD34+ vs. CD342 cells as
represented by the log distance from the mean of each
fluorescence peak. Given that the level of BrdU uptake at day
2.5–3 was similar for both populations, we estimate that the
CD342 population divided .3 cell doublings during the day 4–14
chase.
Without injury, the lack of detectable BrdU incorporation
correlates with q-RT-PCR data to indicate both populations are
quiescent. Following injury both populations have equal levels of
BrdU incorporation indicating a similar degree of cell division
occurred within the peak of proliferation. Beyond 3 days after
injury, CD34+ cells retained a similar level of BrdU indicating
they ceased dividing, while CD342 continued to proliferate as
their incorporation decreased during the chase. Interestingly,
although CD34+ cells did incorporate BrdU following injury, their
percentage did not increase but remained relatively constant.
Therefore we postulated CD34+ cells give rise to more committed
cells while tightly maintaining the parent population during the
course of regeneration. All together, FACS, histological, and BrdU
results indicate CD34+ cells divided early in response to injury and
perhaps gave rise to CD342 cells, which further proliferated
during the course of regeneration.
CD34+/2 Switching is Dependent on Muscle Injury
To test the possibility that activated CD34+ cells are becoming
or giving rise to CD342 cells, we sorted both populations from
injured chicken actin promoter driven EGFP transgenic mice and
transplanted into injured and uninjured quadriceps of C57BL/6
mice. Recipient muscles were then analyzed by FACS to examine
if GFP donor cells gained or lost CD34 when transplanted into
each respective environment. Injured recipient quadriceps were
injected with CTX one day prior to cell transplants. All recipient
muscles were analyzed 3 days post transplant in order to detect
donor cells prior to fusion (n=3 for each condition). CD34
analysis of transplanted GFP cells indicated a distinct pattern of
switching dependent on the state of muscle injury. As predicted,
the majority of injury activated CD34+ donor cells gave rise to, or
directly became CD34 negative. The percentage of CD342 cells
generated from CD34+ donors was slightly more in injured
recipient muscles, although this difference was not significant
(Student’s t-test, p.0.05)(Figure 8A, left graph). Conversely, the
majority of CD342 cells transplanted into injured muscle
remained CD342 (Figure 8A, right graph). To our surprise a
large portion of CD342 cells transplanted into uninjured muscle
became and/or gave rise to CD34+ cells. In contrast to the CD34
expressing phenotype acquired from negative donors following
transplant into uninjured muscles, the percentage of CD342 cells
detected in transplanted injured muscles was very consistent and
statistically significant (Student’s t-test, P#0.05)(Figure 8A, right
graph). These results indicated that the presence or absence of
CD34 on satellite cells is conditionally dependent on muscle
environmental demands and not necessarily hierarchal as initially
hypothesized.
peaks represent unstained controls, green peaks are experimental stained sample. (B) The average percentage of each population per muscle group
relative to all CD452, non-hematopoietic cells. By single factor ANOVA, differences between muscles was statistically significant for CD34+ (#
P#0.05) but not CD342 (P=0.076). (C) The average percentage of CD34+ and CD342 cells within the a7+ (CD452/CD312/Sca12) population. The
ratio of CD34+ over CD342 cells was not statistically significant by single factor ANOVA. A–C are from n=5, 2 month old C57BL/6 mice. Error bars
represent 6SEM.
doi:10.1371/journal.pone.0010920.g005
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PLoS ONE | www.plosone.org 8 June 2010 | Volume 5 | Issue 6 | e10920Because we only studied a short timeframe after injury, it was
unclear if later during the course of regeneration, CD342 cells
ever transitioned back to CD34+. To examine the possibility of
conversion following the peak of proliferation, we sorted and
transplanted CD342 cells isolated from muscles of Myf5
nlacZ/+
mice 3 days post CTX injury directly into uninjured (n=3) and
Figure 6. Following acute injury, CD342 cells are the more responsive myogenic majority. (A) Relative to all CD452 cells, the average
percentage of CD342 cells in Cardiotoxin (CTX) injected TA’s (n=5 per time point) significantly increased 3 days post injury and declines to near uninjured
levels by day 14 (single factor ANOVA, ?P=#0.05). In contrast, the percentage of CD34+cells remained relatively constantduringcourseofregeneration and
was not statistically significant. (B) 3 days post injury the average percentage of CD342 within the a7+ (CD45/CD312/Sca12) population drastically
increases. This proportion reverts back to near uninjured levels by day 14 and by single factor ANOVA was statistically significant for both CD34+ (# P#0.05)
and CD342 (?P#0.05) populations. (C) q-RT-PCR analysis of cells sorted 3 days post injury from CTX treated limb muscles (n=3), indicates the average
relative expression of all three MRF’s increased in both populations as compared to uninjured muscles depicted in Figure 4B. Comparison of MRF’s levels in
injury reveals both populations express equal levels of key myogenic genes Myf5 and MyoD, while CD342 cells express significantly elevated levels of the
differentiation factor myogenin.S t u d e n t ’ st-test, * P#0.05. Error bars represent 6SEM. A–C are from 2 month old C57BL/6 mice.
doi:10.1371/journal.pone.0010920.g006
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PLoS ONE | www.plosone.org 9 June 2010 | Volume 5 | Issue 6 | e10920Figure 7. Although CD342 cells were more differentiated, both CD34+/2 populations proliferated in response to injury. (A)
Immunostaining of damaged TA, 3 days post injury, reveals that myogenin+ cells within the sight of injury are a7+/CD342. Insets show co-
localization of DAPI with nuclear myogenin and membranous a7 but not CD34 staining. Insets were produced from the original sized merged
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(C57BL/6 recipients). In order to detect the Myf5
nlacZ/+ transgene
in donor cells that may have recently fused or formed immature
myofibers, we harvested recipient muscles 7 days post transplant.
Cyrosections were initially stained with X-gal to identify and
validate the presence of Myf5
nlacZ/+ donor cells. Once b-gal+ cells
were identified (Figure S3), adjacent cryosections were stained with
antibodies against b-gal, CD34, and aSMA as a marker of newly
regenerated myofibers [37,38,39]. Results indicate that activated
CD342 donor cells were myogenic as in both injured and
uninjured recipient muscles they formed new muscle fibers
identified as a-SMA+ with b-gal+ centrally located nuclei
(Figure 8B). In addition, we observed mononuclear b-gal+/
CD34+ cells indicating some CD342 cells revert back to a reserve
state following injury repair (Figure 8C). Altogether, the analysis of
the FACS population dynamics during regeneration and BrdU
pulse-chase studies, suggest that the CD342 population is the
major myogenic population responsive of regeneration after
injury. In addition, the transplant studies indicate that some
CD342 negative cells can localize to the satellite cell position and
express CD34. We propose a mechanism for this reversible
switching of CD34 in response to injury to generate enough
differentiating progeny while maintaining the pool of reserve
satellite cells during regeneration (Figure 9).
Discussion
In recent years several surface receptors, including CD34, have
been described to recognize satellite cells of the skeletal muscle [5].
However, no single surface receptor has proven exclusive to
satellite cells, and CD34 is no exception. By utilizing FACS we set
out to isolate pure populations of satellite cells using a host of
antigens in order to select out contaminating cells that also express
CD34. Our results reveal the population of skeletal muscle cells
characterized as CD452/CD312/Sca12/CD34+/a72, lack
expression of myogenic transcription factors Pax7 and Myf5,d o
not form myotubes in vitro, nor conform to the satellite cell
anatomically defined position under the basal lamina. Therefore,
we conclude CD34 alone is inadequate for selecting pure
populations of satellite cells from the skeletal muscle.
Since the initial observation by Beauchamp et al. (2000), CD34
has been widely used to identify and isolate satellite cells
[9,13,19,40,41,42]. Contrary to the multitude of studies that have
examined CD34+ satellite cells, the CD342 minority remained
uncharacterized. Initially, we predicted that similar to the
hematopoietic system, a linear relationship existed within the
satellite cell compartment of skeletal muscle, where more primitive
CD342 cells give rise to more committed CD34+ cells. Contrary
to our initial hypothesis, our results indicate that following acute
injury CD342 cells represent the more myogenically active
population. Furthermore, the absence or presence of CD34 is
reversible depending on the state of injury.
Currently, an inducible CD34 Cre-Lox reporter model is not
available to directly distinguish between downregulation of CD34
or asymmetric division as possible means for CD34 conversion.
However, BrdU analysis, myogenin expression/staining and
transplant data indicate CD342 cells directly respond and
contribute to muscle regeneration following acute injury. Remark-
ably, despite similar BrdU incorporation at the peak of
proliferation between day 2.5–3 post injury, the percentage of
CD34+ cells did not change over the course regeneration. Because
the absence of CD34 marks a state of activation which seems
reversible, the steady percentage of CD34+ cells throughout injury
suggests a proportion of myogenic cells are programmed and/or
stimulated to maintain a reserve pool of satellite cells during the
course of regeneration. This reversible switch from activation to
dormancy has also been observed with hematopoietic stem cells as
they maintain the stem cell pool following bone marrow injury
[43].
Despite their response following acute injury, CD342 cells were
quiescent in uninjured muscle. This leaves into question the role of
this population during normal muscle homeostasis. Although both
CD34+/2 populations were equally myogenic in culture, freshly
sorted CD342 cells had lower expression of myogenic-related
genes such as Pax7, Pax3, Myf5, MyoD, myogenin, CXCR4, and c-met.
Furthermore, we and other groups have observed that within
24 hours of being seeded satellite cells lose CD34 in culture,
suggesting CD34 is downregulated upon activation [5]. Therefore,
CD342 cells appear to represent more ‘‘primed’’ satellite cells
poised for injury response that can advance further in the
myogenic pathway or upregulate CD34 and revert back to a
reserve state depending on the muscle microenvironment.
Although CD34’s function has yet to be elucidated, reversibility
has been reported with hematopoietic stem cells, suggesting a
similar role or pathway of CD34 regulation may exists between
tissue specific stem cells [44,45]. Interestingly, despite the major
myogenic potential and contribution of CD34+/2 cells to muscle
regeneration, a minority of Sca1+ (CD452/CD312/CD34+)
cells sorted from injured muscle was myogenic in culture,
suggesting another possible state of transition or stem cell reservoir
exists within limb muscles (data not shown)[46].
Although the true function(s) of CD34 remains uncertain, it has
been described that this highly glycosylated sialomucin receptor
not only plays a role in signaling but is important in promoting
both cellular adhesion and repulsion [44,47]. Interestingly in one
study it has been reported that CD34 functions in mast cells to
prevent adhesion [48]. Conversely a separate study has reported
that CD34 functions to promote lymphocyte adhesion via L-
selectin in high endothelial venule cells [49]. Thus, it is possible
that the adhesion role of CD34 is dependant on the presence or
absence of additional surface receptors as a means to modulate
binding or repulsion by various cell types. As aforementioned
satellite cells downregulate CD34 in culture, suggesting this
receptor functions in maintaining an undifferentiated state.
Perhaps such maintenance is linked to adhesion and therefore
downregulation of CD34 is required for migration and subsequent
engraftment within regions of damaged muscle.
By characterizing skeletal muscle satellite cells based on the
presence or absence of CD34 we have identified a key myogenic
population responsible for muscle regenerating following acute
injury as CD342 (a7+/CD452/CD312/Sca12). In addition we
show that the fraction of CD34+ cells remains steady during
homeostasis and injury regeneration. Such evidence suggests,
photographs. Scale bar=50 mm. (B) FACS-analysis of BrdU incorporation in sorted CD34+/2 cells after 3 days pulse, indicates relative to bone marrow
(BM) cells (top right histogram), without injury both populations are quiescent (top histogram). In mice pulsed for 12 hours between 2.5–3 days post
CTX injection, both CD34+/2 cells show nearly equal levels of BrdU incorporation (middle histogram). Mice pulsed for the first 3 days following injury
and then chased to day 14 reveal that CD342 cells retain less BrdU whereas CD34+ cells maintained a similar levels to the day 2.5–3 pulse (bottom
histogram). Green peaks represent IgG Isotype controls, Violet BM mononuclear cells, Blue CD34+ cells, and Red CD342 cells. Schematics next to
histograms portray timelines for each BrdU experiment. Each experimental pulse was conducted with n=3, 2 month old C57BL/6 mice.
doi:10.1371/journal.pone.0010920.g007
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PLoS ONE | www.plosone.org 11 June 2010 | Volume 5 | Issue 6 | e10920Figure 8. Following injury repair CD342 cells can revert to CD34+. (A) CD34+/2 cells sorted from injured (3 days prior) limb muscles of
chicken actin promoter driven EGFP reporter mice, were transplanted into uninjured and injured (1 day prior) quadriceps of C57BL/6 recepients.
Quadriceps were FACS-analyzed 3 days post transplant. Values in the Y-axis correspond to the percentage of GFP CD34+/2 cells detected from each
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PLoS ONE | www.plosone.org 12 June 2010 | Volume 5 | Issue 6 | e10920despite much heterogeneity, the satellite cell pool is highly
regulated in vivo to maintain a reserve pool of CD34+ (a7+/
CD452/CD312/Sca12) cells while producing sufficient num-
bers of differentiated progeny for muscle regeneration.
Materials and Methods
Ethics Statement
This study has been reviewed and approved by the University of
Washington’s Institution Animal Care and Use Committee.
Mice and Animal Care
All mice used for satellite cell characterization (histology, FACS-
analysis of individual muscles and injury, single cell culture,
cytocentrifugation, BrdU and expression analysis) were C57BL/6,
predominantly 2 month old males. Reporter mice used for
cytocentrifugation and/or culture were 1.5 month old Myf5
nLacZ/+
and 4 month old 3F-nlacZ-2F [5,50,51], previously described in
our studies [12,29]. Transplant donor cells were derived from
chicken b-actin promoter driven EGFP or Myf5
nLacZ/+ reporter
mice ages ranging from 6–9 month old [52]. Recipients were
C57BL/6, ages ranging from 2–12 months old. Unless specified
otherwise, each experimental replicate (n=) represents samples
derived from individual animals that were independently pro-
cessed and analyzed. Mice were housed and maintained in a
modified barrier facility located at the University of Washington.
All animal experiments were performed in accordance with
guidelines approved by the University of Washington’s Institution
Animal Care and Use Committee.
FACS
Methods for muscle processing and FACS were followed as
previously described [20]. Typically from pooled preparations
including both hind limb muscles, pectorals and triceps of
individual 2 month old C57BL/6 males, we recover 1.5610
6
mononuclear cells per gram of muscle processed. Samples were
initially stained with biotinylated anti-CD34 in 100 ml PBS with
0.3% BSA per 10
6 cells for 45 minutes (min) on ice, then washed
and resuspended in an antibody cocktail including conjugated
streptavidin and directly conjugated anti-CD45/CD31/Sca-1/a7
for a second 45 min incubation. For single cell deposition DAPI
(Sigma) was added for viability and left in solution prior to sorting
respective donor cell type. The X-axis indicates the state of each recipient muscle prior to transplant (n=3 per condition). Irrespective of the recipient
state, the majority of CD34+ donor cell became or gave rise to CD342 after transplant. Although not statistically significant, this switch slightly
increased in CTX injured recipients. In contrast a large proportion of CD342 cells became or gave rise to CD34+ when transplanted into uninjured
muscle but significantly remained CD342 in injured muscle. Student’s t-test calculated * P#0.05. Error bars represent 6SEM. (B) Sorted CD342 from
CTX injured Myf5
nlacZ/+ mice were transplanted into uninjured (n=3) and injured (n=3) quadriceps muscles. In addition to a mock injection, a7-
(CD45/CD312/Sca12) sorted cell were transplanted into uninjured quadriceps as negative controls (Figures S3 and S4). Recipient muscles were
harvested 7 days after transplant and stained for a-smooth muscle actin (aSMA), b-galactosidase (b-gal) and CD34. Cells engrafted under both
conditions as indicated by b-gal+ central nuclei in aSMA+ fibers (arrowheads). Insets show co-localization of nuclear b-gal with DAPI and cytoplasmic
a-SMA staining. Insets were produced from 406 magnification photographs taken within the same field. (C) Engraftment of CD34- cells into
uninjured muscle reveals conversion of CD342 cells to CD34+ cells. Interestingly CD34+ (line arrow) and CD342 (arrowhead), b-gal+ cells were
observed near b-gal+ myonuclei (solid arrow) indicating donor CD342 cells can form new myofibers, remain CD342 or gain CD34 expression. Scale
bars=50 mm.
doi:10.1371/journal.pone.0010920.g008
Figure 9. Summary of significant results and proposed model of CD34 switching by satellite cells following injury. (A) Following acute
injury the proportion of CD342 cells drastically increases while the CD34+ populations remains to near uninjured levels. Despite the increase of only
CD342 cells, BrdU analysis indicates both populations proliferate shortly after injury (day 3) while CD34+ cells retain BrdU following regeneration (day
14). Such trends indicate that CD34+ population represents the pool of less advanced satellite cells that can generate more differentiated CD342
cells while maintaining their numbers during injury repair. In turn, CD342 cells continue proliferating beyond day 3, indicating this population
supplies the differentiated progeny required for complete muscle regeneration. (B) Although more differentiated cells reside within the CD342
population following injury, the absence of CD34 does not terminally mark differentiation as CD342 cells can revert back to the CD34+ pool of less
advanced satellite cells. Thus activated myogenic cells can switch CD34 expression in response to injury, suggesting that CD34 may play a role in
maintaining a reserve pool of satellite cell in order to prevent depletion during muscle regeneration.
doi:10.1371/journal.pone.0010920.g009
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dilutions, combinations and machine specifications are listed in
Methods S1. Data was acquired at 10,000 events per sample and
cells sorted with a BD Aria I and later Aria II, both using Diva
software. Subsequent analysis and flow cytometry plots were
generated using FlowJo v7.2.5 (TreeStar, Inc.). Average popula-
tion values and standard deviations used for error bars were
calculated from the analysis of individual mice. Graphs, Student’s
t-test and ANOVA statistical analyses were generated using
Microsoft Excel 2003. For transplants, culture and cytocentrifuga-
tion sorted cells were collected in culture media. For reverse and
quantitative PCR, sorted cells were collected in 350 ml RLT lysis
buffer (Qaigen) supplemented with b-mercaptoethanol per
manufacturers instructions and immediately placed on dry ice
and stored at 280uC.
Cell Culture
Clonal cultures were prepared by FACS-Aria mediated single
cell deposition into 96 well trays. Non-clonal cultures cells were
directly sorted into 1.7 ml tubes containing 750 ml media and
seeded manually onto 24 well dishes. All tissue culture dishes were
coated with 0.67% (w/v) Type-A Gelatin (Sigma) in H2O and
allowed to dry prior to use. Culture media consisted of Ham’s F10
supplemented with 15% Horse Serum and final concentration of
2 mM CaCl2, 100 units/ml Penicillin with 100 mg/ml Strepto-
mycin (all from HyClone), and 20 ng/ml bFGF (R&D). Cells were
maintained at 37uC, 5%O2, and 5%CO2 and media was changed
after 4 days. At day 8 in culture, cells were fixed with 2%
formaldehyde (diluted formalin in PBS) and stained with DAPI for
counting clones or X-gal for presence of Myf5
nlacZ/+ or 3F-nlacZ-2F
reporter activity. After DAPI staining, photographs of each single
cell derived colony was taken and used to quantify proliferation.
To avoid counting errors we utilized the ImageJ v1.40 g (Wayne
Rasband, NIH) cell counter plugin (Kurt De Vos, University of
Sheffield) which automatically tallies events labeled by users.
Subsequently every DAPI labeled nuclei including myonuclei were
accounted for in the final cell count. The average cell doubling for
each CD34+/2 population was calculated based on the number
of DAPI+ nuclei counted per colony using the following formula in
Microsoft Excel; colony cell doubling=log (# nuclei counted/2).
Stainings
All muscle cryosections were cut 8 mm, fixed with 2%
formaldehyde for 5 min, washed 36with PBS, then stained with
respective antibodies. For cytocentrifugation staining, freshly
sorted cells were spun onto microscope slides at 800 g RCF, fixed
with 4% formaldehyde for 5 min, washed, and then stained.
Stainings utilizing biotinylated antibodies were first blocked with
Vector labs Streptavidin-Avidin blocking kit. Stainings using
mouse primary antibodies were completed using the M.O.M
staining kit (Vector labs) with some modification to manufacturer’s
instruction. Cryosections were incubated overnight at 4uC with the
M.O.M. mouse IgG blocking reagent and streptavidin conjugated
fluorophores were used in place of avidin conjugates. All
antibodies were diluted in PBS containing 1% BSA (fraction IV,
from Fisher) except when prescribed by M.O.M. kit instructions.
DAB staining for Pax7 (performed on freshly isolated, cytocen-
trifuged cells) was completed using the R.T.U. Vectastain Elite
and ImmPact DAB substrate kits (both from Vector labs) following
manufacturer’s instructions. For X-gal staining, cells and tissue
sections were fixed for 10 min at room temperature with 2%
formaldehyde/0.2% glutaraldehyde and incubated overnight at
37uC with staining solution containing a final concentration of
1 mg/ml X-gal, 5 mM potassium ferricyonide, 5 mM potassium
ferrocyonide, and 2 mM CaCl2 (all from Fisher). All stainings
included negative controls in which primary antibodies or X-gal
was omitted (depicted in Figure S4). Brightfield photographs were
taken with Fisher Micromaster digital inverted microscope with
Infinity optics using Micron v1.05 software. Immunofluorescent
stainings were acquired with a Zeiss Axiovert 200 microscope
equipped with monochrome camera. Controls for immunofluo-
rescent stainings were taken at the same or greater exposure time
as primary stained samples. Monochromatic photographs were
colored then merged with Adobe Photoshop v9.0.2. When
necessary to reduce background, certain photos’ brightness and
contrast levels were adjusted within individual channels prior to
coloring. A list of primary and secondary antibodies, dilutions and
microscope specifications are described in the Methods S1.
Reverse-Transcription and Quantitative-RT-PCR
Methods and reagents for PCR reactions have been previously
described by us [20]. Briefly RNA was purified from sorted cells
using Qaigens RNeasy kit. All reactions were two-step beginning
with cDNA synthesis followed by conventional or quantitative
PCR for specific target genes. The following thermal cycling
conditions were used: 95uC- 7 9 initial activation followed by 94uC-
300;57uC-300;72uC-450, for 35 cycles. Quantitative PCR reactions
were run on an ABI 7900HT PCR system using sybr green PCR
master mix. Results were analyzed using SDS 2.2 software and
relative expressions calculated by comparative Ct method. cDNA
from unsorted muscle mononuclear cells (Figure 1B) or whole
muscle (Figures 4B and 6C) were used for calibration. The
endogenous control was GAPDH. Ct values are listed in the Table
S1. Each sample was derived from specific cell populations sorted
from individual mice. Reactions for each respective sample and
gene were run in triplicate. The relative expression between
samples was used to calculate the average expression values and
SEM for error bars represented in each figure. Primer sequences
for each target gene are listed in Methods S1.
Injury and Transplants
Muscle injury was induced by directly injecting 50 ml and
100 ml per TA and quadriceps, respectively, of 10 mM Naja
nigrcollis cardiotoxin (Calbiochem) in PBS. Donor cells were sorted
as CD452/CD312/Sca12/a7+/CD34+ and CD342 from
injured chicken actin promoter driven EGFP or Myf5
nlacZ/+ limb
muscles injected with CTX 3 days prior to isolation. Cells were
directly injected in 15–20 ml collection media, into uninjured or
injured quadriceps treated with CTX the day prior to cell
transplantation. For GFP cell analysis each recipients qaudricep
(n=12, 6 injured 1 day prior and 6 uninjured) was transplanted
with 50,000 sorted CD34+/2 cells. Recipients of GFP cells were
euthanized 3 days post transplant and GFP donor cells were
analyzed by FACS vs. uninjected injured and uninjured controls.
Donor GFP cells represented ,1% of all a7+ (CD452/CD312/
Sca12) cells. Quadriceps (n=6, 3 injured/3 uninjured) injected
with 10,000 Myf5
nlacZ/+ CD342 sorted cells were harvested 7 days
post transplant and frozen in OCT for subsequent staining. For
negative control, 50,000–150,000 sorted Myf5
nlacZ/+ (CD452/
CD312/Sca12) a7- cells (n=2) were transplanted along with a
single SHAM (media only) injection into uninjured quadriceps.
BrdU Incorporation and Analysis
For each pulse 250 ml of 4 mg/ml BrdU (Sigma) in PBS was
administered daily via intraperitoneal injection. CD34+/2 cells
were sorted from limb muscles, fixed with 4% formaldehyde for 5
minutes, washed with PBS and left overnight at 4uC. Tibialis and
femur bone marrows were collected as a positive control for BrdU
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needle. Fixed cells were processed and stained with PE conjugated
anti-BrdU antibody (BD) according to manufacturer’s protocol.
Briefly cells were further fixed with 70% EtOH, denatured with
2 M HCL, and stained in PBS containing 0.5% Tween20 and
0.5% BSA. Sorted cells were identified as DAPI positive and BrdU
incorporation was defined by comparing positive bone marrow
cells with IgG isotype stained controls.
Supporting Information
Methods S1 Includes antibodies and dilutions, fluorescent
microscope specifications, antibody/fluorophore combinations
used for each FACS experiment, BD flow cytometer specifications,
and primers.
Found at: doi:10.1371/journal.pone.0010920.s001 (0.12 MB
DOC)
Figure S1 FACS size selection strategy. In order to remove
duplets and debris we first gate on the tight population of small,
low granulated events located at the bottom left of the Forward
Scatter Area (FSC-A, x-axis) vs. Side Scatter Area (SSC-A, y-axis)
graph. Next we select events by Forward Side Scatter Area (FSC-
A, x-axis) vs. Width (FSC-W, y-axis) to remove the smallest and
largest events. Finally we remove events that are too granulated by
Side Scatter Area (SSC-A, x-axis) vs. Side Scatter Width (SSC-W,
y-axis) then move to antigen selection depicted in Figure 5A. For
single cell deposition DAPI negative cells (live cells) were selected
prior to antigen selection (not shown).
Found at: doi:10.1371/journal.pone.0010920.s002 (1.18 MB TIF)
Figure S2 Following injury the majority of a7 integrin+
cells are negative for CD34, a-smooth muscle actin, and
CD31. Cryosection staining for a-smooth muscle actin (aSMA),
CD31 and CD34 illustrates the majority of a7 integrin+ cells arising
3 days post CTX injury, are not endothelial or smooth muscle cells.
(A) aSMA and CD31 staining shows the smooth muscle cells are
confined to large vessels within injured muscle. (B) aSMA and a7
integrin staining confirmsthat the a7 integrin+ cells arenot vascular
smoothmusclecellswithindamaged areasofmuscle(C)Staining for
CD34 and a7 integrin shows the a7 integrin+ cells in the injured
area are CD34-, while the majority of CD34+ cells represent vessels
in the less injured region. Scale bars=50 mm.
Found at: doi:10.1371/journal.pone.0010920.s003 (5.21 MB TIF)
Figure S3 X-gal staining reveals the presence CD34-
Myf5
nlacZ/+ donor cells in CTX injured and uninjured
quadriceps. 10,000 sorted CD34- Myf5
nlacZ/+ cells were trans-
planted into CTX injured (n=3) and uninjured (n=3) quadriceps.
Prior to immunostaining, X-gal was used to identify and confirmed
the presence Myf5
nlacZ/+ donor cells. Scale bars=50 mm.
Found at: doi:10.1371/journal.pone.0010920.s004 (8.33 MB TIF)
Figure S4 Staining controls. Each figure’s negative controls
omitting primary antibodies or X-gal, positive control for X-gal,
and negative transplant control. (A) Fig. 1C Pax7, CD34 and a7
integrin staining control. (C) Fig. 2 Pax7, laminin, and CD34
control. (B) Fig. 4A right panels; cultured Myf5 nlacZ/+ cells
treated with stain solution containing and omitting x-gal. Fig. 4A
right panels; cytocentrifuged sorted endothelial cells (CD45-/
CD31+/Sca1+) stained with anti-Pax7 and unsorted mononuclear
cells stained with secondary antibody as negative controls for Pax7
DAB staining. (D) CTX injured muscle staining control for
Figures 7A and S2. (E) Fig. 8B&C b-gal and CD34 staining
control. Far right panel portrays cryosection from (CD45-/
CD31-/Sca1-) a7 integrin negative transplanted cells which
stained negative for b-gal and positive for aSMA only in vascular
smooth muscle cells. Scale bars=50 mm.
Found at: doi:10.1371/journal.pone.0010920.s005 (2.99 MB TIF)
Table S1 q-RT-PCR average Ct values for each figure.
Found at: doi:10.1371/journal.pone.0010920.s006 (0.07 MB
DOC)
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